高危HPV RNA原位杂交在转移性头颈部鳞癌细胞学涂片与液基制片中的应用
该研究评估高危HPV RNA原位杂交(ISH)在转移性头颈部鳞状细胞癌(SCC)的常规涂片和液基细胞学(LBC)制片中的效用。结论认为HR-HPV ISH可可靠用于涂片或LBC,尤其当细胞块不可用或细胞稀少时,可作为FNAC标本中确定HPV状态的初始检测方法。
要点
- HR-HPV RNA ISH可在细胞学涂片或LBC制片上可靠进行,尤其适用于细胞块不可用或细胞稀少时。
- 高信号数量时结果易判读,低或稀少信号时判读具有挑战性。
- HR-HPV ISH可作为转移性SCC的FNAC标本中确定HPV状态的初始检测方法。
核心结论
- HR-HPV ISH可可靠用于涂片或LBC制片,尤其当细胞块不可用或细胞稀少时。
- HR-HPV ISH可作为FNAC标本中确定转移性SCC HPV状态的初始检测方法。
研究设计与样本
- 在27张涂片和14份LBC制片上行HR-HPV ISH,结果判读为阳性、不确定或阴性。
主要发现
- 所有转移性HPV阴性SCC均为HR-HPV ISH阴性。
关键数值与推荐
- HR-HPV RNA ISH结果判读为阳性、不确定或阴性。
- 高信号数量时结果易判读,低或稀少信号数量时判读具有挑战性。
临床怎么用
- 在FNAC标本中,尤其细胞块不可用或细胞稀少时,可采用HR-HPV ISH在涂片或LBC制片上确定HPV状态。
- HR-HPV ISH可作为转移性SCC的FNAC标本中确定HPV状态的初始检测方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High-risk human papillomavirus (HR-HPV) status is critical for the diagnosis, prognosis, and treatment of patients with oropharyngeal squamous cell carcinoma (OPSCC). Patients often present with enlarged cervical nodes, and fine-needle aspiration cytology (FNAC) is frequently the initial diagnostic procedure. Although p16 is the most widely used surrogate marker, problems with interpretation can limit its utility in FNAC. HR-HPV RNA in situ hybridization (ISH) has emerged as a specific way to assess HPV status on cell block preparations of cervical nodes. The authors evaluated the utility of HR-HPV ISH in conventional smears and liquid-based cytology (LBC) preparations of metastatic head and neck squamous cell carcinoma (SCC). METHODS: Thirty-one aspirates of proven, HPV-related SCC (confirmed by p16 and/or HR-HPV ISH in corresponding surgical specimens) were selected. Ten aspirates of HPV-negative SCC were also retrieved. HR-HPV ISH was performed on 27 smears and 14 LBC preparations. All results were scored as positive, equivocal, or negative. RESULTS: Eighty-four percent of metastatic, HPV-related SCCs were positive for HR-HPV RNA ISH, with high number of signals (n = 19) and low number of signals (n = 7), whereas five HPV-related SCCs were equivocal. All metastatic, HPV-negative SCCs were negative for HR-HPV ISH. CONCLUSIONS: HR-HPV ISH can be reliably performed on smears or LBC preparations, particularly when cell blocks are unavailable or paucicellular. Results were easy to interpret when high numbers of signals were present but were challenging in aspirates with low or rare number of signals. The current study suggests that HR-HPV ISH could be used as the initial testing modality for determining HPV status in FNAC specimens of metastatic SCC.
引用
- Velez Torres JM, Alkathery T, Tjendra Y, et al. Utility of high-risk HPV RNA chromogenic in situ hybridization in cytology smears and liquid-based preparations from metastatic head and neck squamous cell carcinoma. Cancer Cytopathol. 2022. PMID: 36350307. doi:10.1002/cncy.22659
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。